Mécanismes de sensibilité/résistance des cellules tumorales aux inhibiteurs de réparation de l'ADN Dbait.

Wael Jdey
theses.fr (ABES)
November 25, 2016
Cited by 0

Related Papers

Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors
|Clinical Cancer Research|2016|42
Drugs driven synthetic lethality: getting rid of tumor genetics with combination of Dbait and PARP inhibitors
|European Journal of Cancer|2016|0
Abstract 1110: AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer
|Cancer Research|2017|0
Data from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors
|Unknown|2023|0
Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP Inhibitors
|Unknown|2023|0